| Date | Acquired company | Acquiring company | Amount | Related |
|---|---|---|---|---|
| 2016-07-26 | BIND Therapeutics (USA - MA) | Pfizer (USA - NY) | $40 million | Cancer - Oncology |
| 2016-07-22 | Synta Pharmaceuticals (USA - MA) | Madrigal Pharmaceuticals (USA - PA) | Cardiovascular diseases Metabolic diseases Liver diseases |
|
| 2016-07-21 | Relypsa (USA - CA) | Galenica Group (Switzerland) | $1.53 billion | Kidney diseases - Renal diseases - Gastrointestinal diseases |
| 2016-07-14 | RedoxTherapies (USA - MA) | Juno Therapeutics (USA - CA) | $10 million in cash and milestones | Cancer - Oncology |
| 2016-07-14 | Pro Farma (Switzerland) | Recordati (Italy) | CHF 16 million | |
| 2016-07-13 | Biosafe Group (Switzerland) | GE Healthcare (USA - WI) | undisclosed | Technology - Services Regenerative medicine |
| 2016-07-05 | Medivation (USA - CA) | Sanofi (France) | $ 9.4 billion (€ 8.2 billion) | Cancer - Oncology |
| 2016-07-05 | Cormorant Pharmaceuticals (Sweden) | BMS (USA - NY) | up to $ 520 million | Cancer - Oncology Rare diseases |
| 2016-06-30 | Finox Biotech (Switzerland) | Gedeon Richter (Hungary) | CHF 190 million (€174.3 million) | Women health Sterility Biosimilar products |
| 2016-06-28 | Relief Therapeutics (Switzerland) | Therametrics (Switzerland) | drug development | |
| 2016-06-27 | Merial (France) | Boehringer Ingelheim (Germany) | €4.7 billion | Veterinary medicine |
| 2016-06-27 | Boehringer Ingelheim consumer healthcare business (Germany) | Sanofi (France) | consumer healthcare |
|
| 2016-06-27 | Blue Stream Laboratories (USA - MA) | Charles River Laboratories (USA - MA) | undisclosed | |
| 2016-06-24 | Anacor Pharmaceuticals (US - CA) | Pfizer (USA - NY) | $ 5.2 billion (€ 4.6 billion) | Dermatological diseases |
| 2016-06-23 | Imugen (USA - MA) | Oxford Immunotec (UK) | $22.2 million | |
| 2016-06-16 | Therametrics CRO subsidiaries (THERAMetrics GmbH, THERAMetrics S.p.A., THERAMetrics CRU, S.r.l. and THERAMetrics S.r.l.) | Accelovance (USA - MD) | undisclosed | CRO clinical research |
| 2016-06-13 | Biotie Therapies (Finland) | Acorda Therapeutics (USA - NY) | $363 million | Neurodegenerative diseases CNS diseases |
| 2016-06-10 | Therametrics Clinical Supply Services (Italy) | Fin Posillipo (Italy) | undisclosed | CRO |
| 2016-06-09 | Afferent Pharmaceuticals (USA - CA) | Merck&Co (USA - NJ) | up to $ 1.25 billion | |
| 2016-06-03 | Baxalta (USA - IL) | Shire (UK - USA) | $32 billion | Rare diseases |
